Methylphenidate-induced neuroleptic malignant syndrome: A case report [1]

Primary Care Companion to the Journal of Clinical Psychiatry

Volumn 8, Issue 1, 2006, Pages 47-

  Basil, Biju ^a   Mathews, Maju ^a   Budur, Kumar ^b  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; DIPHENHYDRAMINE; HALOPERIDOL; LORAZEPAM; METHYLPHENIDATE;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; BEHAVIOR DISORDER; CASE REPORT; CLINICAL FEATURE; CREATINE KINASE BLOOD LEVEL; DYSTONIA; FEVER; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE; LETTER; MALE; NEUROLEPTIC MALIGNANT SYNDROME; SCHOOL CHILD; SEDATION; TACHYCARDIA;

EID: 33748525824     PISSN: 15235998     EISSN: None     Source Type: Journal    
DOI: 10.4088/pcc.v08n0109a     Document Type: Letter

References (2)

1. Ehara H, Maegaki Y, Takeshita K, Neuroleptic malignant syndrome and methylphenidate. Pediatr Neurol 1998;19:299-301
2. Mann SC, Caroff SN, Keck PE, et al. NMS and Related Conditions. 2nd ed. Washington, DC: American Psychiatric Press; 2003:1-44